Promising Mango-Flavored Pill May Revolutionize Treatment for Intestinal Worms

Wed Apr 02 2025 12:29:26 GMT+0300 (Eastern European Summer Time)
Promising Mango-Flavored Pill May Revolutionize Treatment for Intestinal Worms

A groundbreaking mango-flavored tablet combining two anti-parasitic drugs shows potential in treating intestinal worms, affecting over 1.5 billion worldwide.


Researchers have developed a promising new treatment for intestinal worms, which afflict countless individuals globally, particularly children in developing nations. The mango-flavored pill, a combination of two existing anti-parasitic drugs, demonstrated efficacy in clinical trials and could play a significant role in combating these parasitic infections.

 

A recent study has highlighted a novel approach to combating intestinal worms through a new mango-flavored pill that combines two established anti-parasitic medications. This innovative tablet aims to address the parasitic infections that affect approximately 1.5 billion people worldwide, heavily burdening children in many developing regions. Researchers assert that this combination therapy exhibits greater effectiveness than existing treatments and could significantly enhance management strategies for these infections.

Commonly termed soil-transmitted helminths (STHs), these parasites, such as whipworm and hookworm, proliferate in areas with inadequate sanitation, posing severe gastrointestinal symptoms, malnutrition, and anemia. Currently, prevention measures are severely limited, hinging mainly on improved hygiene practices. The research findings, published in the Lancet, suggest that this new medication could assist affected nations in achieving the World Health Organization's eradication targets.

This convenient pill can be administered either as a single tablet or in a course of three tablets over consecutive days, facilitating large-scale mass treatment programs. According to project leader Professor Jose Muñoz, "It is easy to administer, as it is one single pill." The dual-drug approach is also anticipated to reduce the risk of drug resistance, a growing concern among health experts, thereby prolonging treatment efficacy.

Clinical trials conducted on 1,001 children aged 5 to 18 in Ethiopia, Kenya, and Mozambique indicated promising results when the pill was used in conjunction with praziquantel. However, additional research is needed to explore its effectiveness against various STHs and in different age groups.

Professor Hany Elsheikha from the University of Nottingham noted that while the study presents a considerable advancement in treatment, it is not without uncertainties. "We don't know if the results would be the same for adults, younger children, or in different global contexts," he explained.

The research team has submitted their findings to regulatory bodies in Europe and Africa, with results expected by early 2025. Furthermore, a larger trial involving 20,000 participants is being organized in Kenya and Ghana to assess the pill's broader applicability. Dr. Stella Kepha of the Kenya Medical Research Institute echoed the sentiment of cautious optimism, noting that the pill holds "great potential for improving the health of affected communities," while acknowledging that further steps are needed to ensure its successful rollout.

MORE ON THEME

Tue, 01 Apr 2025 19:35:02 GMT

UNICEF Reports Alarming Child Casualties Amid Renewed Gaza Offensive

Tue, 01 Apr 2025 19:35:02 GMT
Tue, 01 Apr 2025 15:30:41 GMT

U.S. Family Planning Aid Cuts: A Looming Crisis for Women's Health

Tue, 01 Apr 2025 15:30:41 GMT
Tue, 01 Apr 2025 11:29:51 GMT

**Haitian Gangs Launch Bold Attack, Free Hundreds of Inmates Amid Rising Violence**

Tue, 01 Apr 2025 11:29:51 GMT
Wed, 26 Mar 2025 14:37:37 GMT

U.S. Aid Shift: Trump Administration Cuts Vaccine Support for Developing Nations

Wed, 26 Mar 2025 14:37:37 GMT
Mon, 24 Mar 2025 21:33:56 GMT

UNAids Chief Warns US Funding Cuts May Lead to Catastrophic Rise in HIV Cases and Deaths

Mon, 24 Mar 2025 21:33:56 GMT
Mon, 24 Mar 2025 17:29:35 GMT

US Funding Cuts to HIV Programs Could Lead to Catastrophic Outcomes, Warns UNAids Chief

Mon, 24 Mar 2025 17:29:35 GMT
Thu, 20 Mar 2025 13:11:02 GMT

Abduction Crisis Escalates in Ethiopia's Oromia Region

Thu, 20 Mar 2025 13:11:02 GMT
Thu, 20 Mar 2025 09:30:25 GMT

Surge in Kidnappings: Armed Attack on Bus Passengers in Ethiopia

Thu, 20 Mar 2025 09:30:25 GMT
Sun, 16 Mar 2025 19:39:11 GMT

Unraveling the Dark Truth Behind Labor Exploitation: East African Women in Saudi Arabia

Sun, 16 Mar 2025 19:39:11 GMT
Sun, 16 Mar 2025 04:09:06 GMT

The Hidden Costs of Domestic Work: Tragedies Faced by East African Women in Saudi Arabia**

Sun, 16 Mar 2025 04:09:06 GMT
Sun, 16 Mar 2025 04:07:50 GMT

The Dark Side of the Domestic Worker Trade: Fatal Realities for East African Women in Saudi Arabia**

Sun, 16 Mar 2025 04:07:50 GMT
Fri, 14 Mar 2025 15:04:23 GMT

Sudan Enacts Import Ban on Kenya Amid Civil War Tensions

Fri, 14 Mar 2025 15:04:23 GMT
Wed, 12 Mar 2025 00:49:57 GMT

Thousands Celebrate Cultural Handover at Ethiopia's Gada Ceremony

Wed, 12 Mar 2025 00:49:57 GMT
Tue, 11 Mar 2025 17:03:10 GMT

Tuberculosis Resurgence: The Global Impact of U.S. Aid Cuts

Tue, 11 Mar 2025 17:03:10 GMT
Sun, 09 Mar 2025 17:11:49 GMT

Church Donation by President Ruto Triggers Protests in Kenya

Sun, 09 Mar 2025 17:11:49 GMT
Sat, 08 Mar 2025 10:52:47 GMT

Nigeria to Receive Life-Saving Leprosy Treatments After Year-Long Scarcity

Sat, 08 Mar 2025 10:52:47 GMT
Fri, 28 Feb 2025 04:27:14 GMT

Small Advances in Global Biodiversity Protection Amid Political Tensions

Fri, 28 Feb 2025 04:27:14 GMT
Thu, 27 Feb 2025 05:22:25 GMT

Myanmar's Cyber Fraud Crisis: A Harrowing Look at Trafficked Workers

Thu, 27 Feb 2025 05:22:25 GMT
Tue, 25 Feb 2025 21:42:24 GMT

Unknown Outbreak in Eastern Congo: Health Officials Investigate Bat Link

Tue, 25 Feb 2025 21:42:24 GMT
Mon, 24 Feb 2025 21:47:44 GMT

Scottish Businessman Disappearance: Tragic Conclusion in Kenya

Mon, 24 Feb 2025 21:47:44 GMT

Follow us

© 2024 SwissX REDD UK ltd. All Rights Reserved.